Literature DB >> 7295477

Erythrocyte and plasma aspirin esterase.

H J Rylance, R C Wallace.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 7295477      PMCID： PMC1401796          DOI： 10.1111/j.1365-2125.1981.tb01244.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Hydrolysis of salicylsalicylic acid in human blood and plasma: a comparison with acetylsalicylic acid.

Authors:  L Harthon; M Hedström
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

2.  Plasma aspirin esterases in normal individuals, patients with alcoholic liver disease and rheumatoid arthritis: characterization and the importance of the enzymic components.

Authors:  K D Rainsford; N L Ford; P M Brooks; H M Watson
Journal:  Eur J Clin Invest       Date:  1980-10       Impact factor: 4.686

3.  Drug inhibition of whole blood aspirin esterase.

Authors:  H J Rylance; R C Wallace
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335
  3 in total
  3 in total

Review 1.  Clinical significance of esterases in man.

Authors:  F M Williams
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

2.  Reaction of human albumin with aspirin in vitro: mass spectrometric identification of acetylated lysines 199, 402, 519, and 545.

Authors:  Mariya S Liyasova; Lawrence M Schopfer; Oksana Lockridge
Journal:  Biochem Pharmacol       Date:  2009-10-27       Impact factor: 5.858

3.  Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanisms.

Authors:  Bianca Rocca; Giovanna Petrucci
Journal:  Thrombosis       Date:  2012-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.